GLYKO BIOMEDICAL LTD

Certification of termination of registration of a class of securities (Section 12(g))

5,7

General form for quarterly reports under Section 13 or 15(d)

4,7

4

Notification of late filing of Form 10-Q

4,7

5,7

General form for quarterly reports under Section 13 or 15(d)

5,7

5,7

5,7

Annual report pursuant to Section 13 or 15(d)

5,7

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G)

General form for quarterly reports under Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

Annual report pursuant to Section 13 or 15(d)

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

General form for quarterly reports under Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

No description available

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G)

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G)

No description available

No description available

Annual Report Scanned (Paper)

Definitive Proxy Statement

No description available

No description available

Notification of late filing of Form 10-K

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G)

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

No description available

No description available

No description available

Annual Report Scanned (Paper)

Definitive Proxy Statement

No description available

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G)

Definitive Proxy Statement

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G)

1